CompletedPhase 2

Effect Of Intravenous IntralipidTherapyon Pregnancy Outcome in Women With History of Recurrent Implantation Failure Undergoing Intracytoplasmic Sperm Injection-Embryo Transfer Cycle: A Randomized Controlled Trial

142 participantsStarted 2015-01-01

Plain-language summary

To evaluate the effect ofempiricintralipidinfusion therapy on pregnancy outcomes in patient withunexplained recurrentimplantation failure (RIF) undergoIntracytoplasmic sperm injection (ICSI).

Who can participate

Age range21 Years – 42 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age \< 42 years * BMI \< 30 kg/m2 * history of 3 or more recurrent implantation failure undergoing Intracytoplasmic Sperm Injection (ICSI ) cycle. exclusion criteria * women with medical contraindications of intralipidinfusion. * uterine fibroid. * endometrial polyp. * endometriosis,hydrosalpinx. * intrauterine adhesion and uterine anomalies. * Women with positive thrombophilia screen. * diminished ovarian reserve. * severe male factor infertility . * chronic medical illnesses which may contribute in impaired chance of pregnancy .

What they're measuring

pregnancy rate

Timeframe: 14 day post embryo transfer day

Trial details

NCT IDNCT03374163

SponsorKing Fahad Medical City

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2017-06-30

View on ClinicalTrials.gov More Infertility Due to Nonimplantation trials